Intervention for cancer patients with mild cognitive impairment and their caregivers
A Patient-Caregiver Behavioral Intervention for Older Adults With Cancer and Mild Cognitive Impairment-2
NA · Duke University · NCT05144516
This study tests a video program designed to help cancer patients with mild cognitive issues and their caregivers improve communication and emotional support.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Duke University (other) |
| Locations | 1 site (Durham, North Carolina) |
| Trial ID | NCT05144516 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effectiveness of a dyadic intervention program for cancer patients experiencing mild cognitive impairment and their caregivers. Participants will engage in six 60-minute video-conference sessions, facilitated through a tablet computer provided by the study. Assessments will be conducted before, after, and one month post-intervention to measure outcomes related to cognitive and emotional well-being. The program focuses on enhancing communication and support within the patient-caregiver dyad.
Who should consider this trial
Good fit: Ideal candidates include individuals aged 65 or older with Stage I-IV breast, colon, rectal, or lung cancer and mild cognitive impairment.
Not a fit: Patients with advanced dementia or significant visual or hearing impairments may not benefit from this intervention.
Why it matters
Potential benefit: If successful, this intervention could improve the quality of life and cognitive functioning for cancer patients and their caregivers.
How similar studies have performed: Other studies have shown promise in dyadic interventions for chronic illnesses, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Patient inclusion criteria include: 1. Patients with Stage I-IV breast, gastrointestinal (GI), genitourinary (GU), or lung cancer (including extensive stage small cell lung cancer), diagnosed within two years; age 65 or older. 2. Participants must be living at home (either in her/his own home). 3. Participants must be fluent in English and able to learn basic skills for using a tablet computer to conduct videoconference treatment sessions. 4. Exhibit Mild Cognitive Impairment/Concerns 5. Have an informal family caregiver. Inclusion Criteria: (Partner or family member) inclusion criteria include: 1. Caregivers are 18 older. 2. Be fluent in English and able to learn basic skills for using a tablet computer to conduct videoconference treatment sessions. 3. Either co-reside with the patient or spend at least 3-4 hours day caregiving. 4. Not exhibit cognitive impairment. Exclusion Criteria: 1. Participant has visual or hearing impairments that preclude participation. 2. Participant has dementia and do not have the capacity to participate. 3. Have a serious untreated psychiatric illness as documented in medical chart review. 4. The patient and the caregiver score less than a 3 on the National Comprehensive Cancer Network (NCCN) Distress Thermometer (DT) on a scale 0 to 10 to screen for distress. At least one dyad member must experience distress.
Where this trial is running
Durham, North Carolina
- Duke University — Durham, North Carolina, United States (RECRUITING)
Study contacts
- Principal investigator: Katherine Ramos, Ph.D. — Duke University
- Study coordinator: Katherine Ramos, Ph.D.
- Email: Katherine.Ramos@duke.edu
- Phone: 9194163434
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cancer, Cognitive Impairment, Aging, Behavioral Intervention, Mental Health, Communication